These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36147586)

  • 1. Effects of proinflammatory cytokines on lacrimal gland myoepithelial cells contraction.
    Garriz A; Morokuma J; Bowman M; Pagni S; Zoukhri D
    Front Ophthalmol (Lausanne); 2022; 2():. PubMed ID: 36147586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models.
    Hawley D; Tang X; Zyrianova T; Shah M; Janga S; Letourneau A; Schicht M; Paulsen F; Hamm-Alvarez S; Makarenkova HP; Zoukhri D
    Sci Rep; 2018 Jul; 8(1):9919. PubMed ID: 29967327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Phospholipase C Pathway and Calcium Mobilization in Oxytocin-Induced Contraction of Lacrimal Gland Myoepithelial Cells.
    Gárriz A; Aubry S; Wattiaux Q; Bair J; Mariano M; Hatzipetrou G; Bowman M; Morokuma J; Ortiz G; Hamrah P; Dartt DA; Zoukhri D
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):25. PubMed ID: 34812841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1β activates matrix metalloproteinase-2 to alter lacrimal gland myoepithelial cell structure and function.
    Morokuma J; Gárriz A; Toribio D; Pagni S; Zoukhri D
    Front Ophthalmol (Lausanne); 2024; 4():1415002. PubMed ID: 38984107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the adenylate cyclase/cyclic AMP pathway in oxytocin-induced lacrimal gland myoepithelial cells contraction.
    Gárriz A; Morokuma J; Toribio D; Zoukhri D
    Exp Eye Res; 2023 Aug; 233():109526. PubMed ID: 37290630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacrimal Gland Histopathology and Secretory Function in Sjögren's Syndrome Mice Model Treated with
    Susanto AJ; Purwanto B; Mudigdo A; Wasita B
    Antiinflamm Antiallergy Agents Med Chem; 2023; 21(3):166-172. PubMed ID: 36305140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.
    Zoukhri D; Hodges RR; Byon D; Kublin CL
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1429-36. PubMed ID: 11980857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Matricellular Protein SPARC Decreases in the Lacrimal Gland At Adulthood and During Inflammation.
    Feldt J; Garriz A; Rodriguez Benavente MC; Woodward AM; Zoukhri D; Argüeso P
    Invest Ophthalmol Vis Sci; 2022 Dec; 63(13):8. PubMed ID: 36479944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic DNA activates the AIM2 inflammasome and STING pathways to induce inflammation in lacrimal gland myoepithelial cells.
    Yang M; Delcroix V; Lennikov A; Wang N; Makarenkova HP; Dartt DA
    Ocul Surf; 2023 Oct; 30():263-275. PubMed ID: 37769964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
    Sullivan DA; Edwards JA
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
    Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome.
    Zoukhri D; Hodges RR; Rawe IM; Dartt DA
    Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
    Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
    Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
    Ma X; Zou J; He L; Zhang Y
    Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cells.
    Beauregard C; Brandt PC; Chiou GC
    Exp Eye Res; 2003 Jul; 77(1):109-14. PubMed ID: 12823994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.
    Zoukhri D; Macari E; Choi SH; Kublin CL
    J Neurochem; 2006 Jan; 96(1):126-35. PubMed ID: 16300639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.